<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) comprise a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal disorders of the haematopoietic stem cell and primarily involve cells of the myeloid lineage </plain></SENT>
<SENT sid="1" pm="."><plain>Using cDNA microarrays comprising 6000 human genes, we studied the gene expression profiles in the neutrophils of 21 MDS patients, seven of which had the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e>, and two <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients when compared with the neutrophils from pooled healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>Data analysis showed a high level of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of gene expression between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, most probably reflecting the underlying karyotypic and <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Nevertheless, several genes were commonly up or down-regulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The most up-regulated genes included RAB20, ARG1, ZNF183 and ACPL </plain></SENT>
<SENT sid="5" pm="."><plain>The RAB20 gene is a member of the Ras gene superfamily and ARG1 promotes cellular proliferation </plain></SENT>
<SENT sid="6" pm="."><plain>The most down-regulated genes include COX2, CD18, FOS and IL7R </plain></SENT>
<SENT sid="7" pm="."><plain>COX2 is anti-apoptotic and promotes cell survival </plain></SENT>
<SENT sid="8" pm="."><plain>Many genes were identified that are differentially expressed in the different <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subtypes and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>A subset of genes was able to discriminate patients with the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> from patients with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> and a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="10" pm="."><plain>The microarray expression results for several genes were confirmed by real-time quantitative polymerase chain reaction </plain></SENT>
<SENT sid="11" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-specific expression changes identified are likely to be biologically important in the pathophysiology of this disorder </plain></SENT>
</text></document>